Description

Oral formulations of drugs contain a number of compounds other than the active ingredient such as fillers and binders. Intravenous injection of an oral medication containing talc can result in pulmonary talcosis. This was a problem in the past when drug addicts were crushing and injecting oral methadone tablets.


 

Risk factors:

(1) oral tablet containing talc and a drug of abuse (opioid, stimulant, etc)

(2) repeated injections

(3) failure to solubilize or filter the material

 

Clinical features:

(1) dyspnea on exertion, eventually at rest

(2) chronic cough

(3) deterioration in pulmonary function tests

 

Imaging findings:

(1) diffuse fine micronodules with ground glass attenuation (microemboli)

(2) pulmonary fibrosis which can become massive

(3) emphysema

(4) pulmonary hypertension

 

A lung biopsy may demonstrate the talc within blood vessels, macrophages or granulomas.

 

If there is a right-to-left shunt then talc microemboli can end up in the heart, brain, kidney, eye and skin.

 

Differential diagnosis:

(1) occupational talcosis

(2) other complications of drug abuse

(3) infection (AIDS, tuberculosis, etc)

(4) complications of smoking

 


To read more or access our algorithms and calculators, please log in or register.